Aveanna Healthcare Holdings Inc. - AVAH STOCK NEWS

Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH) reported a strong third quarter 2021, with revenue rising 12.4% to $411.3 million and net income of $2.1 million, or $0.01 per diluted share. Adjusted EBITDA grew 14.6% to $45.8 million. The company announced acquisitions of Comfort Care and Accredited, expected to enhance their market position, with projected revenues of $97 million and $115 million, respectively. Full-year revenue guidance has been adjusted to $1.675 to $1.680 billion, lowered from $1.745 billion.

Aveanna Healthcare Holdings (NASDAQ: AVAH) will release its third quarter results after market close on November 15, 2021. A conference call is scheduled for November 16, 2021, at 10:00 a.m. Eastern Time, accessible via phone and webcast. The company, based in Atlanta, operates in 30 states, providing services like nursing, therapy, and home health care. Aveanna aims to offer a high-quality, lower-cost alternative to prolonged hospitalization, catering to pediatric and adult patients. For further details, visit the investor relations section of Aveanna's website.

Butterfly Network (NYSE: BFLY) has announced the appointment of Dr. Erica Schwartz to its Board of Directors and Troy Quander as Senior Vice President of Regulatory and Quality. These strategic additions aim to enhance the company’s capabilities in medical imaging and regulatory affairs. Dr. Schwartz, a former Deputy Surgeon General, brings extensive healthcare management experience, while Quander adds over 25 years of regulatory expertise. Both are expected to facilitate Butterfly's mission of democratizing medical imaging and driving innovative solutions in clinical practice.

Aveanna Healthcare Holdings reported a 24% increase in revenue to $436.1 million for Q2 2021, driven by substantial growth in Private Duty Services and Home Health & Hospice segments.

Gross margin rose 37.5% to $146.6 million, with a net income of $1.3 million compared to a net loss of $77.6 million in Q2 2020. Adjusted EBITDA grew by 30.6% to $48.8 million.

The company reaffirmed a revenue guidance of at least $1,745 million for 2021, highlighting operational progress and successful debt refinancing.

Aveanna Healthcare announced it will release its second quarter results on August 11, 2021, after market close, followed by a conference call on August 12, 2021, at 10:00 a.m. Eastern Time. Investors can join the call via phone or through a live webcast on the company’s website. The call will provide insights into the company's financial performance and future outlook. Aveanna operates across 30 states, offering a wide range of pediatric and adult healthcare services, aiming to provide high-quality and cost-effective alternatives to prolonged hospitalization.

Aveanna Healthcare is set to join the Russell 2000 Index effective June 28, 2021. This inclusion follows the annual reconstitution of the Russell indexes, capturing the 4,000 largest US stocks by market capitalization. Being part of the Russell 3000 Index allows Aveanna to gain visibility as it executes growth strategies and value creation opportunities. CEO Tony Strange expressed optimism about the company's journey in public markets. Aveanna, headquartered in Atlanta, provides a range of healthcare services across 30 states, including nursing and rehabilitation.

Aveanna Healthcare Holdings reported a 17.4% increase in revenue for Q1 2021, totaling $417.2 million, up from $355.2 million in Q1 2020. Gross margin rose 22.4% to $131.7 million, with net income at $5.8 million, or $0.04 per diluted share. Adjusted net income per diluted share was $0.08, while Adjusted EBITDA surged 46.7% to $43.7 million. The company successfully completed its IPO in May 2021, raising $432.4 million to reduce debt, enhancing its financial position.

Aveanna Healthcare will release its Q1 2021 results after market close on May 25, 2021. A conference call to discuss these results will take place on May 26, 2021, at 10:00 a.m. ET. Investors can participate by calling 1-877-407-0789 (domestic) or 1-201-689-8562 (international). A replay of the call will be available for one week. Aveanna, based in Atlanta, is a leading provider of home care services for medically complex patients, addressing significant challenges in the U.S. healthcare system.

Aveanna Healthcare has commenced trading on the Nasdaq Global Select Market under the ticker symbol AVAH. The company completed its initial public offering of 38,236,000 shares at a public price of $12.00 per share, with an additional option for underwriters to purchase up to 5,735,400 shares. This IPO signifies a milestone for Aveanna as it aims to enhance care for patients across the United States. The offering's joint lead managers include Barclays and J.P. Morgan among others.